Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation

Journal of Controlled Release

Volumn 219, Issue , 2015, Pages 622-631

  Renukaradhya, Gourapura J ^a   Narasimhan, Balaji ^b   Mallapragada, Surya K ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b Iowa State University   (United States)

Author keywords

Animal models; Nanovaccines; Translation; Vaccine efficacy

Indexed keywords

ANIMALS; ANTIGENS; NANOPARTICLES; TRANSLATION (LANGUAGES); VACCINES; VIRUSES;

ANIMAL MODEL; IMMUNOMODULATORS; INFECTIOUS DISEASE; NANOVACCINES; SUSTAINED RELEASE; VACCINE DEVELOPMENT; VACCINE EFFICACIES; VIRUS-LIKE PARTICLES;

DISEASES;

IMMUNOLOGICAL ADJUVANT; IMMUNOMODULATING AGENT; NANOCARRIER; NANOPARTICLE; POLYMER; SUBUNIT VACCINE; VACCINE; VIRUS ANTIGEN;

ANIMAL MODEL; ARTICLE; CROSS PROTECTION; DRUG DELIVERY SYSTEM; FARM ANIMAL; IMMUNOCOMPETENT CELL; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SUSTAINED DRUG RELEASE; VIRUS LIKE AGENT; ANIMAL; DISEASE MODEL; HUMAN; INHALATIONAL DRUG ADMINISTRATION; RESPIRATORY TRACT DISEASES; TRANSLATIONAL RESEARCH;

ADMINISTRATION, INHALATION; ANIMALS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; RESPIRATORY TRACT DISEASES; TRANSLATIONAL MEDICAL RESEARCH; VACCINES;

EID: 84947253023     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.09.047     Document Type: Article

References (222)

1. M.F. Lipscomb, J. Hutt, J. Lovchik, T. Wu, and C.R. Lyons The pathogenesis of acute pulmonary viral and bacterial infections: investigations in animal models Annu. Rev. Pathol. 5 2010 223 252
2. T. Ferkol, and D. Schraufnagel The global burden of respiratory disease Ann Am. Thorac. Soc. 11 2014 404 406
3. A. Jegerlehner, F. Zabel, A. Langer, K. Dietmeier, G.T. Jennings, P. Saudan, and M.F. Bachmann Bacterially produced recombinant influenza vaccines based on virus-like particles PLoS One 8 2013 e78947
4. A.M. Arvin, and H.B. Greenberg New viral vaccines Virology 344 2006 240 249
5. J. Ehreth The global value of vaccination Vaccine 21 2003 596 600
6. J.M. Fontana, E. Alexander, and M. Salvatore Translational research in infectious disease: current paradigms and challenges ahead Transl. Res. 159 2012 430 453
7. C. Martin Montañés, and B. Gicquel New tuberculosis vaccines Enferm. Infecc. Microbiol. Clin. 29 Suppl. 1 2011 57 62
8. D.M. Lindell, S.B. Morris, M.P. White, L.E. Kallal, P.K. Lundy, T. Hamouda, J.R. Baker Jr., and N.W. Lukacs A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without th2 associated vaccine-enhanced disease PLoS One 6 2011 e21823
9. J.H. Wilson-Welder, M.P. Torres, M.J. Kipper, S.K. Mallapragada, M.J. Wannemuehler, and B. Narasimhan Vaccine adjuvants: current challenges and future approaches J. Pharm. Sci. 98 4 2009 1278 1316
10. K.A. Ross, L.M. Huntimer, J.E. Vela Ramirez, J.R. Adams, S.L. Carpenter, M.L. Kohut, T. Bronich, R. Webby, K.L. Legge, S.K. Mallapragadal, M.J. Wannemuehler, and B. Narasimhan Vaccine technologies against avian influenza: current approaches and new directions J. Biomed. Nanotechnol. 10 2014 2261 2294
11. L. Du, G. Zhao, S. Sun, X. Zhang, X. Zhou, Y. Guo, Y. Li, Y. Zhou, and S. Jiang A critical ha1 neutralizing domain of h5n1 influenza in an optimal conformation induces strong cross-protection PLoS One 8 2013 e53568
12. S.K. Mallapragada, and B. Narasimhan Immunomodulatory biomaterials Int. J. Pharm. 364 2008 265 271
13. B.A. t Hart, W.M. Bogers, K.G. Haanstra, F.A. Verreck, and C.H. Kocken The translational value of non-human primates in preclinical research on infection and immunopathology Eur. J. Pharmacol. 759 2015 69 83
14. C.A. Shaw, M. Ciarlet, B.W. Cooper, L. Dionigi, P. Keith, K.B. O'Brien, M. Rafie-Kolpin, and P.R. Dormitzer The path to an rsv vaccine Curr. Opin. Virol. 3 2013 332 342
15. B. Magenheim, and S. Benita Nanoparticle charecterization: a comprehensive physicochemical approach STP Pharma. Sci. 1 1991 221 241
16. A. Nel, T. Xia, L. Madler, and N. Li Toxic potential of materials at the nanolevel Science 311 2006 622 627
17. J. Panyam, and V. Labhasetwar Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Deliv. Rev. 55 2003 329 347
18. R. Duncan Nanomedicine gets clinical Mater. Today 8 2005 16 17
19. R. Langer, J.L. Cleland, and J. Hanes New advances in microsphere-based single-dose vaccines Adv. Drug Deliv. Rev. 28 1997 97 119
20. J. Hanes, M. Chiba, and R. Langer Polymer microspheres for vaccine delivery Pharm. Biotechnol. 6 1995 389 412
21. K.A. Woodrow, K.M. Bennett, and D.D. Lo Mucosal vaccine design and delivery Annu. Rev. Biomed. Eng. 14 2012 17 46
22. A. des Rieux, V. Fievez, M. Garinot, Y.J. Schneider, and V. Preat Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach J. Control. Release 116 2006 1 27
23. A. Bacon, J. Makin, P.J. Sizer, I. Jabbal-Gill, M. Hinchcliffe, L. Illum, S. Chatfield, and M. Roberts Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens Infect. Immun. 68 2000 5764 5770
24. U. Bertram, M.C. Bernard, J. Haensler, P. Maincent, and R. Bodmeier In situ gelling nasal inserts for influenza vaccine delivery Drug Dev. Ind. Pharm. 36 2010 581 593
25. S.M. Moghimi, and J. Szebeni Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties Prog. Lipid Res. 42 2003 463 478
26. C. Foged, B. Brodin, S. Frokjaer, and A. Sundblad Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model Int. J. Pharm. 298 2005 315 322
27. S.P. Kasturi, I. Skountzou, R.A. Albrecht, D. Koutsonanos, T. Hua, H.I. Nakaya, R. Ravindran, S. Stewart, M. Alam, M. Kwissa, F. Villinger, N. Murthy, J. Steel, J. Jacob, R.J. Hogan, A. Garcia-Sastre, R. Compans, and B. Pulendran Programming the magnitude and persistence of antibody responses with innate immunity Nature 470 2011 543 547
28. S.E. McNeil Nanotechnology for the biologist J. Leukoc. Biol. 78 2005 585 594
29. A.E. Gregory, R. Titball, and D. Williamson Vaccine delivery using nanoparticles Front. Cell. Infect. Microbiol. 3 2013 13
30. M. Diwan, P. Elamanchili, M. Cao, and J. Samuel Dose sparing of cpg oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery Curr. Drug Deliv. 1 2004 405 412
31. M.E. Lutsiak, G.S. Kwon, and J. Samuel Biodegradable nanoparticle delivery of a th2-biased peptide for induction of th1 immune responses J. Pharm. Pharmacol. 58 2006 739 747
32. F. Alexis, E. Pridgen, L.K. Molnar, and O.C. Farokhzad Factors affecting the clearance and biodistribution of polymeric nanoparticles Mol. Pharm. 5 2008 505 515
33. S. Nagayama, K. Ogawara, Y. Fukuoka, K. Higaki, and T. Kimura Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics Int. J. Pharm. 342 2007 215 221
34. S.E. Howe, D.J. Lickteig, K.N. Plunkett, J.S. Ryerse, and V. Konjufca The uptake of soluble and particulate antigens by epithelial cells in the mouse small intestine PLoS One 9 2014 e86656
35. S.C. Corr, C.C. Gahan, and C. Hill M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis FEMS Immunol. Med. Microbiol. 52 2008 2 12
36. P. Jani, G.W. Halbert, J. Langridge, and A.T. Florence The uptake and translocation of latex nanospheres and microspheres after oral administration to rats J. Pharm. Pharmacol. 41 1989 809 812
37. P. Jani, G.W. Halbert, J. Langridge, and A.T. Florence Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency J. Pharm. Pharmacol. 42 1990 821 826
38. C. Primard, N. Rochereau, E. Luciani, C. Genin, T. Delair, S. Paul, and B. Verrier Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells Biomaterials 31 2010 6060 6068
39. D.L. Bolton, K. Song, R.L. Wilson, P.A. Kozlowski, G.D. Tomaras, B.F. Keele, R.V. Lovingood, S. Rao, and M. Roederer Comparison of systemic and mucosal vaccination: impact on intravenous and rectal siv challenge Mucosal Immunol. 5 2012 41 52
40. H. Hasegawa, E. van Reit, and H. Kida Mucosal immunization and adjuvants Curr. Top. Microbiol. Immunol. 386 2015 371 380
41. J. Holmgren, C. Czerkinsky, N. Lycke, and A.M. Svennerholm Mucosal immunity: implications for vaccine development Immunobiology 184 1992 157 179
42. H. Dlugonska, and M. Grzybowski Mucosal vaccination-an old but still vital strategy Ann. Parasitol. 58 2012 1 8
43. K. Inaba, M. Inaba, M. Naito, and R.M. Steinman Dendritic cell progenitors phagocytose particulates, including Bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo J. Exp. Med. 178 1993 479 488
44. S. Chadwick, C. Kriegel, and M. Amiji Nanotechnology solutions for mucosal immunization Adv. Drug Deliv. Rev. 62 2010 394 407
45. J.P. Kraehenbuhl, and M.R. Neutra Epithelial m cells: differentiation and function Annu. Rev. Cell Dev. Biol. 16 2000 301 332
46. D.Y. Kim, A. Sato, S. Fukuyama, H. Sagara, T. Nagatake, I.G. Kong, K. Goda, T. Nochi, J. Kunisawa, S. Sato, Y. Yokota, C.H. Lee, and H. Kiyono The airway antigen sampling system: respiratory m cells as an alternative gateway for inhaled antigens J. Immunol. 186 2011 4253 4262
47. R.K. Gupta, A.C. Chang, and G.R. Siber Biodegradable polymer microspheres as vaccine adjuvants and delivery systems Dev. Biol. Stand. 92 1998 63 78
48. S.K. Lai, Y.Y. Wang, and J. Hanes Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues Adv. Drug Deliv. Rev. 61 2009 158 171
49. N.K. Garg, S. Mangal, H. Khambete, and R.K. Tyagi Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers Recent Pat. Drug Deliv. Formul. 4 2010 114 128
50. N. Mishra, A.K. Goyal, S. Tiwari, R. Paliwal, S.R. Paliwal, B. Vaidya, S. Mangal, M. Gupta, D. Dube, A. Mehta, and S.P. Vyas Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers Expert Opin. Ther. Pat. 20 2010 661 679
51. C.M. Lehr Lectin-mediated drug delivery: the second generation of bioadhesives J. Control. Release 65 2000 19 29
52. H.O. Alpar, S. Somavarapu, K.N. Atuah, and V.W. Bramwell Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery Adv. Drug Deliv. Rev. 57 2005 411 430
53. E. Mathiowitz, J.S. Jacob, Y.S. Jong, G.P. Carino, D.E. Chickering, P. Chaturvedi, C.A. Santos, K. Vijayaraghavan, S. Montgomery, M. Bassett, and C. Morrell Biologically erodable microspheres as potential oral drug delivery systems Nature 386 1997 410 414
54. M. Dawson, E. Krauland, D. Wirtz, and J. Hanes Transport of polymeric nanoparticle gene carriers in gastric mucus Biotechnol. Prog. 20 2004 851 857
55. A.K. Shakya, and K.S. Nandakumar Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases J. R. Soc. Interface 10 2013 15
56. T. Brenza, L. Petersen, Y. Zhang, L. Huntimer, A. Ramer-Tait, J. Hostetter, M. Wannemuehler, and B. Narasimhan Pulmonary biodistribution and cellular uptake of intranasally administered monodisperse particles Pharm. Res. 32 2015 1368 1382
57. S.L. Haughney, K. Ross, P. Boggiatto, M.J. Wannemuehler, and B. Narasimhan Effect of nanovaccine chemistry on humoral immune response kinetics and maturation Nanoscale 6 2014 13770 13778
58. A. Li, J. Moon, W. Abraham, H. Suh, J. Elkhader, M. Seidman, M. Yen, E.-J. Im, M. Foley, D. Barouch, and D. Irvine Generation of effector memory t cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination Sci. Transl. Med. 5 2013 204ra30
59. C. Nembrini, A. Stano, K. Dane, M. Ballester, A.J. ven der Vlies, B. Marsland, M. Swartz, and J. Hubbell Nanoparticle conjugation of antigen enhances cytotoxic t-cell responses in pulmonary vaccination Proc. Natl. Acad. Sci. U. S. A. 108 2011 E989 E997
60. T. Nochi, Y. Yuki, H. Takahashi, S.-I. Sawada, M. Mejima, T. Kohda, N. Harada, I. Kong, A. Sato, N. Kataoka, D. Tokuhara, S. Kurokawa, Y. Takahashi, H. Tsukada, S. Kozaki, K. Akiyoshi, and H. Kiyono Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines Nat. Mater. 9 2010 572 578
61. K. Ross, S. Haughney, L. Petersen, P. Boggiatto, M. Wannemuehler, and B. Narasimhan Deposition and uptake behavior of pathogen-mimicking nanovaccines in the first 48 hours Adv. Healthcare Mater. 3 2014 1071 1077
62. S. Seong, and P. Matzinger Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses Nat. Rev. Immunol. 4 2004 469 478
63. E. Rytting, J. Nguyen, X. Wang, and T. Kissel Biodegradable polymeric nanocarriers for pulmonary drug delivery Expert Opin. Drug Deliv. 5 2008 629 639
64. P. Malyala, J. Chesko, M. Ugozzoli, A. Goodsell, F. Zhou, M. Vajdy, D.T. O'Hagan, and M. Singh The potency of the adjuvant, cpg oligos, is enhanced by encapsulation in plg microparticles J. Pharm. Sci. 97 2008 1155 1164
65. A. Bolhassani, S. Safaiyan, and S. Rafati Improvement of different vaccine delivery systems for cancer therapy Mol. Cancer 10 2011 3
66. C. Thomas, A. Rawat, L. Hope-Weeks, and F. Ahsan Aerosolized pla and plga nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis b vaccine Mol. Pharm. 8 2011 405 415
67. B. Semete, L. Booysen, Y. Lemmer, L. Kalombo, L. Katata, J. Verschoor, and H.S. Swai In vivo evaluation of the biodistribution and safety of plga nanoparticles as drug delivery systems Nanomedicine 6 2010 662 671
68. A.L. Armstead, and B. Li Nanomedicine as an emerging approach against intracellular pathogens Int. J. Nanomedicine 6 2011 3281 3293
69. M. Singh, M. Briones, and D.T. O'Hagan A novel bioadhesive intranasal delivery system for inactivated influenza vaccines J. Control. Release 70 2001 267 276
70. B. Baras, M.A. Benoit, L. Dupre, O. Poulain-Godefroy, A.M. Schacht, A. Capron, J. Gillard, and G. Riveau Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen Infect. Immun. 67 1999 2643 2648
71. M.J. Shephard, D. Todd, B.M. Adair, A.L. Po, D.P. Mackie, and E.M. Scott Immunogenicity of bovine parainfluenza type 3 virus proteins encapsulated in nanoparticle vaccines, following intranasal administration to mice Res. Vet. Sci. 74 2003 187 190
72. T.F. Gajewski, M. Pinnas, T. Wong, and F.W. Fitch Murine th1 and th2 clones proliferate optimally in response to distinct antigen-presenting cell populations J. Immunol. 146 1991 1750 1758
73. B. Binjawadagi, V. Dwivedi, C. Manickam, K. Ouyang, J.B. Torrelles, and G.J. Renukaradhya An innovative approach to induce cross-protective immunity against porcine reproductive and respiratory syndrome virus in the lungs of pigs through adjuvanted nanotechnology-based vaccination Int. J. Nanomedicine 9 2014 1519 1535
74. B. Binjawadagi, V. Dwivedi, C. Manickam, K. Ouyang, Y. Wu, L.J. Lee, J.B. Torrelles, and G.J. Renukaradhya Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs Int. J. Nanomedicine 9 2014 679 694
75. L.J. Peek, C.R. Middaugh, and C. Berkland Nanotechnology in vaccine delivery Adv. Drug Deliv. Rev. 60 2008 915 928
76. A. Azizi, A. Kumar, F. Diaz-Mitoma, and J. Mestecky Enhancing oral vaccine potency by targeting intestinal m cells PLoS Pathog. 6 2010 e1001147
77. M. Manocha, P.C. Pal, K.T. Chitralekha, B.E. Thomas, V. Tripathi, S.D. Gupta, R. Paranjape, S. Kulkarni, and D.N. Rao Enhanced mucosal and systemic immune response with intranasal immunization of mice with hiv peptides entrapped in plg microparticles in combination with Ulex europaeus-i lectin as m cell target Vaccine 23 2005 5599 5617
78. P.N. Gupta, K. Khatri, A.K. Goyal, N. Mishra, and S.P. Vyas M-cell targeted biodegradable plga nanoparticles for oral immunization against hepatitis b J. Drug Target. 15 2007 701 713
79. B. Nayak, A.K. Panda, P. Ray, and A.R. Ray Formulation, characterization and evaluation of rotavirus encapsulated pla and plga particles for oral vaccination J. Microencapsul. 26 2009 154 165
80. C. Thomas, V. Gupta, and F. Ahsan Influence of surface charge of plga particles of recombinant hepatitis b surface antigen in enhancing systemic and mucosal immune responses Int. J. Pharm. 379 2009 41 50
81. M. Yoshida, and J.E. Babensee Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation J. Biomed. Mater. Res. A 79 2006 393 408
82. D.F. Nixon, C. Hioe, P.D. Chen, Z. Bian, P. Kuebler, M.L. Li, H. Qiu, X.M. Li, M. Singh, J. Richardson, P. McGee, T. Zamb, W. Koff, C.Y. Wang, and D. O'Hagan Synthetic peptides entrapped in microparticles can elicit cytotoxic t cell activity Vaccine 14 1996 1523 1530
83. S.L. Demento, W. Cui, J.M. Criscione, E. Stern, J. Tulipan, S.M. Kaech, and T.M. Fahmy Role of sustained antigen release from nanoparticle vaccines in shaping the t cell memory phenotype Biomaterials 33 2012 4957 4964
84. D.A. Blair, D.L. Turner, T.O. Bose, Q.M. Pham, K.R. Bouchard, K.J. Williams, J.P. McAleer, L.S. Cauley, A.T. Vella, and L. Lefrancois Duration of antigen availability influences the expansion and memory differentiation of t cells J. Immunol. 187 2011 2310 2321
85. M. Kovacsovics-Bankowski, and K.L. Rock A phagosome-to-cytosol pathway for exogenous antigens presented on mhc class i molecules Science 267 1995 243 246
86. J.J. Moon, H. Suh, A. Bershteyn, M.T. Stephan, H. Liu, B. Huang, M. Sohail, S. Luo, S.H. Um, H. Khant, J.T. Goodwin, J. Ramos, W. Chiu, and D.J. Irvine Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses Nat. Mater. 10 2011 243 251
87. S.T. Reddy, A.J. van der Vlies, E. Simeoni, V. Angeli, G.J. Randolph, C.P. O'Neil, L.K. Lee, M.A. Swartz, and J.A. Hubbell Exploiting lymphatic transport and complement activation in nanoparticle vaccines Nat. Biotechnol. 25 2007 1159 1164
88. A. Heit, F. Schmitz, T. Haas, D.H. Busch, and H. Wagner Antigen co-encapsulated with adjuvants efficiently drive protective t cell immunity Eur. J. Immunol. 37 2007 2063 2074
89. D.M. Smith, J.K. Simon, and J.R. Baker Jr. Applications of nanotechnology for immunology Nat. Rev. Immunol. 13 2013 592 605
90. C. Schliehe, C. Redaelli, S. Engelhardt, M. Fehlings, M. Mueller, N. van Rooijen, M. Thiry, K. Hildner, H. Weller, and M. Groettrup Cd8-dendritic cells and macrophages cross-present poly(d,l-lactate-co-glycolate) acid microsphere-encapsulated antigen in vivo J. Immunol. 187 2011 2112 2121
91. J.P. Amorij, G.F. Kersten, V. Saluja, W.F. Tonnis, W.L. Hinrichs, B. Slutter, S.M. Bal, J.A. Bouwstra, A. Huckriede, and W. Jiskoot Towards tailored vaccine delivery: needs, challenges and perspectives J. Control. Release 161 2012 363 376
92. B. Carrillo-Conde, A. Garza, J. Anderegg, and B. Narasimhan Protein adsorption on biodegradable polyanhydride microparticles J. Biomed. Mater. Res. A 95 2010 40 48
93. B. Carrillo-Conde, E. Schiltz, J. Yu, F. Minion, G. Phillips, M.J. Wannemuehler, and B. Narasimhan Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis protein antigens Acta Biomater. 6 2010 3110 3119
94. A.S. Determan, J.R. Graham, K.A. Pfeiffer, and B. Narasimhan The role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheres J. Microencapsul. 23 2006 832 843
95. A.S. Determan, B.G. Trewyn, V.S. Lin, M. Nilsen-Hamilton, and B. Narasimhan Encapsulation, stabilization, and release of bsa-fitc from polyanhydride microspheres J. Control. Release 100 2004 97 109
96. M.J. Kipper, E. Shen, A. Determan, and B. Narasimhan Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery Biomaterials 23 2002 4405 4412
97. M.J. Kipper, J.H. Wilson, M.J. Wannemuehler, and B. Narasimhan Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism J. Biomed. Med. Res. 76 2006 798 810
98. S.K. Lopac, M.P. Torres, J.H. Wilson-Welder, M.J. Wannemuehler, and B. Narasimhan Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres J. Biomed. Mater. Res. B 91 2009 938 947
99. L. Petersen, A. Ramer-Tait, S. Broderick, C. Kong, B. Ulery, K. Rajan, M.J. Wannemuehler, and B. Narasimhan Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants Biomaterials 32 2011 6815 6822
100. L. Petersen, C. Sackett, and B. Narasimhan A novel, high throughput method to study in vitro protein release from polymer nanospheres J. Comb. Chem. 12 2010 51 56
101. L. Petersen, C. Sackett, and B. Narasimhan High throughput analysis of protein stability in polyanhydride nanoparticles Acta Biomater. 6 2010 3873 3881
102. M.P. Torres, A.S. Determan, G.L. Anderson, S.K. Mallapragada, and B. Narasimhan Amphiphilic polyanhydrides for protein stabilization and release Biomaterials 28 2007 108 116
103. B. Ulery, D. Kumar, A. Ramer-Tait, M.J. Wannemuehler, D. Metzger, and B. Narasimhan Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases PLoS One 6 2011 e17642
104. B. Ulery, L. Petersen, Y. Phanse, C. Kong, S. Broderick, D. Kumar, A. Ramer-Tait, B. Carrillo-Conde, B. Bellaire, K. Rajan, M.J. Wannemuehler, and B. Narasimhan Rational design of "pathogen-mimicking" amphiphilic materials as nanoadjuvants Sci. Rep. 1 2011 198
105. B. Ulery, Y. Phanse, A. Sinha, M.J. Wannemuehler, B. Narasimhan, and B. Bellaire Polymer chemistry influences uptake of nanospheres by immune cells Pharm. Res. 26 2009 683 690
106. J. Fu, J. Fiegel, E. Krauland, and J. Hanes New polymeric carriers for controlled drug delivery following inhalation or injection Biomaterials 23 2002 4425 4433
107. L. Huntimer, J.H. Wilson-Welder, K. Ross, B. Carrillo-Conde, L. Pruisner, C. Wang, B. Narasimhan, M.J. Wannemuehler, and A. Ramer-Tait Single immunization of a suboptimal dose of antigen encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses J. Biomed. Mater. Res. 101B 2013 91 98
108. B. Carrillo-Conde, E. Schiltz, J. Yu, F.C. Minion, G.J. Phillips, M.J. Wannemuehler, and B. Narasimhan Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens Acta Biomater. 6 2010 3110 3119
109. A.S. Determan, J.H. Wilson, M.J. Kipper, M.J. Wannemuehler, and B. Narasimhan Protein stability in the presence of polymer degradation products: consequences for controlled release formulations Biomaterials 27 2006 3312 3320
110. S.L. Haughney, L.K. Petersen, A.D. Schoofs, A.E. Ramer-Tait, J.D. King, D.E. Briles, M.J. Wannemuehler, and B. Narasimhan Retention of structure, antigenicity, and biological function of pneumococcal surface protein a (pspa) released from polyanhydride nanoparticles Acta Biomater. 9 2013 8262 8271
111. L. Petersen, Y. Phanse, A.E. Ramer-Tait, M.J. Wannemuehler, and B. Narasimhan Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen Mol. Pharm. 9 2012 874 882
112. K.A. Ross, H. Loyd, W. Wu, L. Huntimer, M.J. Wannemuehler, S. Carpenter, and B. Narasimhan Structural and antigenic stability of h5n1 hemagglutinin trimer upon release from polyanhydride nanoparticles J. Biomed. Mater. Res. A 102 2014 4161 4168
113. L. Petersen, L. Xue, K. Rajan, M. Wannemuehler, and B. Narasimhan The simultaneous effect of polymer chemistry and device geometry on the in vitro activation of murine dendritic cells Biomaterials 30 2009 5131 5142
114. M.P. Torres, J.H. Wilson-Welder, S.K. Lopac, Y. Phanse, B. Carrillo-Conde, A. Ramer-Tait, B. Bellaire, M.J. Wannemuehler, and B. Narasimhan Polyanhydride microparticles enhance dendritic cell antigen presentation and activation Acta Biomater. 7 2011 2857 2864
115. L.M. Huntimer, K.A. Ross, R.J. Darling, N.E. Winterwood, P. Boggiatto, B. Narasimhan, A.E. Ramer-Tait, and M. Wannemuehler Polyanhydride nanovaccine platform enhances antigen-specific cytotoxic t cell responses Technology 2 2014 171 175
116. J.R. Adams, M. Goswami, N.L.B. Pohl, and S.K. Mallapragada Synthesis and functionalization of virus-mimicking cationic block copolymers with pathogen-associated carbohydrates as potential vaccine adjuvants RSC Adv. 4 2014 15655 15663
117. J.R. Adams, S.L. Haughney, and S.K. Mallapragada Effective polymer adjuvants for sustained delivery of protein subunit vaccines Acta Biomater. 14 2015 104 114
118. M.J. Newman, C.W. Todd, and M. Balasubramanian Design and development of adjuvant-active non-ionic block copolymers J. Pharm. Sci. 87 1998 1357 1362
119. H.C. Arca, M. Gunbeyaz, and S. Senel Chiosan-based systems for the delivery of vaccine antigens Expert Rev. Vaccines 8 2009 937 953
120. E.A. McNeela, D. O'Connor, I. Jabbal-Gill, S.S. Davis, M. Pizza, S. Peppoloni, R. Rappuoli, and K.H. Mills A mucosal vaccine against diphtheria: formulation of cross reacting material (crm(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and th2 responses following nasal delivery Vaccine 19 2000 1188 1198
121. Y. Shibata, L.A. Foster, W.J. Metzger, and Q.N. Myrvik Alveolar macrophage priming by intravenous administration of chitin particles, polymers of n-acetyl-d-glucosamine, in mice Infect. Immun. 65 1997 1734 1741
122. S. Aiba Studies on chitosan: 4. Lysozymic hydrolysis of partially n-acetylated chitosans Int. J. Biol. Macromol. 14 1992 225 228
123. P. Guermonprez, J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena Antigen presentation and t cell stimulation by dendritic cells Annu. Rev. Immunol. 20 2002 621 667
124. G. Nagao, K. Ishii, K. Hirota, K. Makino, and H. Terada Role of lipid rafts in innate immunity and phagocytosis of polystyrene latex microspheres Colloids Surf. B: Biointerfaces 84 2011 317 324
125. K.L. Schully, S. Sharma, K.J. Peine, J. Pesce, M.A. Elberson, M.E. Fonseca, A.M. Prouty, M.G. Bell, H. Borteh, M. Gallovic, E.M. Bachelder, A. Keane-Myers, and K.M. Ainslie Rapid vaccination using an acetalated dextran microparticulate subunit vaccine confers protection against triplicate challenge by Bacillus anthracis Pharm. Res. 30 2013 1349 1361
126. T.L. Bowersock, H. Hogesesh, M. Suckow, P. Guimond, S. Martin, D. Borie, S. Torregrosa, H. Park, and K. Park Oral vaccination of animals with antigens encapsulated in alginate microspheres Vaccine 17 1999 1804 1811
127. N. Rydell, L. Stertman, and I. Sjoholm Starch microparticles as vaccine adjuvants Expert Opin. Drug Deliv. 2 2005 807 828
128. P. Walpita, J. Barr, M. Sherman, C.F. Basler, and L. Wang Vaccine potential of nipah virus-like particles PLoS One 6 2011 e18437
129. L.H. Lua, N.K. Connors, F. Sainsbury, Y.P. Chuan, N. Wibowo, and A.P. Middelberg Bioengineering virus-like particles as vaccines Biotechnol. Bioeng. 111 2014 425 440
130. L.E. Richert, A.E. Servid, A.L. Harmsen, A. Rynda-Apple, S. Han, J.A. Wiley, T. Douglas, and A.G. Harmsen A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose Vaccine 30 2012 3653 3665
131. I. Kola, and J. Landis Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 3 2004 711 715
132. J. Mestas, and C.C. Hughes Of mice and not men: differences between mouse and human immunology J. Immunol. 172 2004 2731 2738
133. J. Seok, H.S. Warren, A.G. Cuenca, M.N. Mindrinos, H.V. Baker, W. Xu, D.R. Richards, G.P. McDonald-Smith, H. Gao, L. Hennessy, C.C. Finnerty, C.M. Lopez, S. Honari, E.E. Moore, J.P. Minei, J. Cuschieri, P.E. Bankey, J.L. Johnson, J. Sperry, A.B. Nathens, T.R. Billiar, M.A. West, M.G. Jeschke, M.B. Klein, R.L. Gamelli, N.S. Gibran, B.H. Brownstein, C. Miller-Graziano, S.E. Calvano, P.H. Mason, J.P. Cobb, L.G. Rahme, S.F. Lowry, R.V. Maier, L.L. Moldawer, D.N. Herndon, R.W. Davis, W. Xiao, and R.G. Tompkins Inflammation and L.S.C.R.P. host response to injury, genomic responses in mouse models poorly mimic human inflammatory diseases Proc. Natl. Acad. Sci. U. S. A. 110 2013 3507 3512
134. S. Perrin Preclinical research: make mouse studies work Nature 507 2014 423 425
135. D.A. Groneberg, C. Witt, U. Wagner, K.F. Chung, and A. Fischer Fundamentals of pulmonary drug delivery Respir. Med. 97 2003 382 387
136. H. Chung, S.J. Pamp, J.A. Hill, N.K. Surana, S.M. Edelman, E.B. Troy, N.C. Reading, E.J. Villablanca, S. Wang, J.R. Mora, Y. Umesaki, D. Mathis, C. Benoist, D.A. Relman, and D.L. Kasper Gut immune maturation depends on colonization with a host-specific microbiota Cell 149 2012 1578 1593
137. U.D. Gupta, and V.M. Katoch Animal models of tuberculosis Tuberculosis (Edinb.) 85 2005 277 293
138. J.F. Papin, R.F. Wolf, S.D. Kosanke, J.D. Jenkins, S.N. Moore, M.P. Anderson, and R.C. Welliver Sr. Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants Am. J. Physiol. Lung Cell. Mol. Physiol. 304 2013 L530 L539
139. J. Krejci, K. Nechvatalova, M. Blahutkova, and M. Faldyna The respiratory tract in pigs and its immune system: a review Vet. Med. 58 2013 206 220
140. E.M. Liebler-Tenorio, and R. Pabst Malt structure and function in farm animals Vet. Res. 37 2006 257 280
141. V.G. Sasseville, J.L. Mankowski, A. Baldessari, C. Harbison, S. Laing, S. Kaliyaperumal, K. Matz-Rensing, A.D. Miller, L.D. Schmidt, J. Kaplan-Kees, E.J. Dick Jr., J.R. Reader, D. Liu, L.K. Crawford, J.H. Lane, S.M. Corner, I.D. Pardo, M.G. Evans, R. Murnane, and K.A. Terio Meeting report: emerging respiratory viral infections and nonhuman primate case reports Vet. Pathol. 50 2013 1145 1153
142. R.E. Palermo, J. Tisoncik-Go, M.J. Korth, and M.G. Katze Old world monkeys and new age science: the evolution of nonhuman primate systems virology ILAR J. 54 2013 166 180
143. D. Kaushal, S. Mehra, P.J. Dideir, and A.A. Lackner The non-human primate model of tuberculosis J. Med. Primatol. 41 2012 191 201
144. M. Jeyanathan, N. Thanthrige-Don, S. Afkhami, R. Lai, D. Damjanovic, A. Zganiacz, X. Feng, X.D. Yao, K.L. Rosenthal, M. Fe Medina, J. Gauldie, H.C. Ertl, and Z. Xing Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent tb protection Mucosal Immunol. 2015
145. Y. Yao, L. Bao, W. Deng, L. Xu, F. Li, Q. Lv, P. Yu, T. Chen, Y. Xu, H. Zhu, J. Yuan, S. Gu, Q. Wei, H. Chen, K.Y. Yuen, and C. Qin An animal model of mers produced by infection of rhesus macaques with MERS coronavirus J. Infect. Dis. 209 2014 236 242
146. A.E. Mayer, J.B. Johnson, and G.D. Parks The neutralizing capacity of antibodies elicited by parainfluenza virus infection of African green monkeys is dependent on complement Virology 460-461 2014 23 33
147. Y. Matsuoka, A. Suguitan Jr., M. Orandle, M. Paskel, K. Boonnak, D.J. Gardner, F. Feldmann, H. Feldmann, M. Marino, H. Jin, G. Kemble, and K. Subbarao African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates J. Virol. 88 2014 8139 8152
148. B. Rockx, K.N. Bossart, F. Feldmann, J.B. Geisbert, A.C. Hickey, D. Brining, J. Callison, D. Safronetz, A. Marzi, L. Kercher, D. Long, C.C. Broder, H. Feldmann, and T.W. Geisbert A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment J. Virol. 84 2010 9831 9839
149. B.G. Jones, R.E. Sealy, R. Rudraraju, V.L. Traina-Dorge, B. Finneyfrock, A. Cook, T. Takimoto, A. Portner, and J.L. Hurwitz Sendai virus-based rsv vaccine protects African green monkeys from rsv infection Vaccine 30 2012 959 968
150. E.A. Simoes, J.P. DeVincenzo, M. Boeckh, L. Bont, J.E. Crowe Jr., P. Griffiths, F.G. Hayden, R.L. Hodinka, R.L. Smyth, K. Spencer, S. Thirstrup, E.E. Walsh, and R.J. Whitley Challenges and opportunities in developing respiratory syncytial virus therapeutics J. Infect. Dis. 211 Suppl. 1 2015 S1 S20
151. K. Yang, and S.M. Varga Mucosal vaccines against respiratory syncytial virus Curr. Opin. Virol. 6 2014 78 84
152. J.M. Warfel, J. Beren, V.K. Kelly, G. Lee, and T.J. Merkel Nonhuman primate model of pertussis Infect. Immun. 80 2012 1530 1536
153. K. Subbarao, and A. Roberts Is there an ideal animal model for SARS? Trends Microbiol. 14 2006 299 303
154. E.E. Zumbrun Mission critical: mobilization of essential animal models for Ebola, nipah, and machupo virus infections Vet. Pathol. 52 2015 18 20
155. L.N. Henning, J.E. Comer, G.V. Stark, B.D. Ray, K.P. Tordoff, K.A. Knostman, and G.T. Meister Development of an inhalational Bacillus anthracis exposure therapeutic model in cynomolgus macaques Clin. Vaccine Immunol. 19 2012 1765 1775
156. V. Mett, J. Lyons, K. Musiychuk, J.A. Chichester, and T. Brasil A plant produced plague vaccine candidate confers protection to monkeys Vaccine 25 2007 3014 3017
157. M.L. Pitt Non-human primates as a model for pneumonic plague Public Workshop on Animal Models and Correlates of Protection for Plague Vaccines 2004 Department of Health and Human Resources, Food and Drug Administration, and Center for Biologics Evlauation and Research (http://www.fda.gov/downloads/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/TranscriptsMinutes/UCM054438.pdf)
158. K.P. Dhondt, and B. Horvat Henipavirus infections: lessons from animal models Pathogens 2 2013 264 287
159. S. Niewiesk Current animal models: cotton rat animal model Curr. Top. Microbiol. Immunol. 330 2009 89 110
160. Y. Zhang, S. Niewiesk, and J. Li Small animal models for human metapneumovirus: cotton rat is more permissive than hamster and mouse Pathogens 3 2014 633 655
161. A.K. Guvenel, C. Chiu, and P.J. Openshaw Current concepts and progress in rsv vaccine development Expert Rev. Vaccines 13 2014 333 344
162. B. Rockx Recent developments in experimental animal models of henipavirus infection Pathog. Dis. 71 2014 199 206
163. N. Zhang, J. Tang, L. Lu, S. Jiang, and L. Du Receptor-binding domain-based subunit vaccines against MERS-CoV Virus Res. 202 2015 151 159
164. J. Oscherwitz, F. Yu, J.L. Jacobs, and K.B. Cease Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthrax Clin. Vaccine Immunol. 20 2013 341 349
165. B.W. Gutting, D. Marchette, R. Sherwood, G.A. Andrews, A. Director-Myska, S.R. Channel, D. Wolfe, A.E. Berger, R.S. Mackie, B.J. Watson, and A. Rukhin Modeling low-dose mortality and disease incubation period of inhalational anthrax in the rabbit J. Theor. Biol. 329 2013 20 31
166. T. Enkirch, and V. von Messling Ferret models of viral pathogenesis Virology 479-480C 2015 259 270
167. I. Margine, and F. Krammer Animal models for influenza viruses: implications for universal vaccine development Pathogens 3 2014 845 874
168. L. Xu, L. Bao, W. Deng, H. Zhu, T. Chen, Q. Lv, F. Li, J. Yuan, Z. Xiang, K. Gao, Y. Xu, L. Huang, Y. Li, J. Liu, Y. Yao, P. Yu, W. Yong, Q. Wei, L. Zhang, and C. Qin The mouse and ferret models for studying the novel avian-origin human influenza a (h7n9) virus Virol. J. 10 2013 253
169. T.C. Sutton, C. Finch, H. Shao, M. Angel, H. Chen, I. Capua, G. Cattoli, I. Monne, and D.R. Perez Airborne transmission of highly pathogenic h7n1 influenza virus in ferrets J. Virol. 88 2014 6623 6635
170. H. Zhu, D. Wang, D.J. Kelvin, L. Li, Z. Zheng, S.W. Yoon, S.S. Wong, A. Farooqui, J. Wang, D. Banner, R. Chen, R. Zheng, J. Zhou, Y. Zhang, W. Hong, W. Dong, Q. Cai, M.H. Roehrl, S.S. Huang, A.A. Kelvin, T. Yao, B. Zhou, X. Chen, G.M. Leung, L.L. Poon, R.G. Webster, R.J. Webby, J.S. Peiris, Y. Guan, and Y. Shu Infectivity, transmission, and pathology of human-isolated h7n9 influenza virus in ferrets and pigs Science 341 2013 183 186
171. H.L. Yen, C.H. Liang, C.Y. Wu, H.L. Forrest, A. Ferguson, K.T. Choy, J. Jones, D.D. Wong, P.P. Cheung, C.H. Hsu, O.T. Li, K.M. Yuen, R.W. Chan, L.L. Poon, M.C. Chan, J.M. Nicholls, S. Krauss, C.H. Wong, Y. Guan, R.G. Webster, R.J. Webby, and M. Peiris Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic h1n1 influenza virus in ferrets Proc. Natl. Acad. Sci. U. S. A. 108 2011 14264 14269
172. K.V. Houser, M.B. Pearce, J.M. Katz, and T.M. Tumpey Impact of prior seasonal h3n2 influenza vaccination or infection on protection and transmission of emerging variants of influenza a(h3n2)v virus in ferrets J. Virol. 87 2013 13480 13489
173. J.H. Kreijtz, E.J. Kroeze, K.J. Stittelaar, L. de Waal, G. van Amerongen, S. van Trierum, P. van Run, T. Bestebroer, T. Kuiken, R.A. Fouchier, G.F. Rimmelzwaan, and A.D. Osterhaus Low pathogenic avian influenza a(h7n9) virus causes high mortality in ferrets upon intratracheal challenge: a model to study intervention strategies Vaccine 31 2013 4995 4999
174. D. Van Riel, V.J. Munster, E. de Wit, G.F. Rimmelzwaan, R.A. Fouchier, A.D. Osterhaus, and T. Kuiken H5n1 virus attachment to lower respiratory tract Science 312 2006 399
175. S.G. Paquette, S.S. Huang, D. Banner, L. Xu, A. Leomicronn, A.A. Kelvin, and D.J. Kelvin Impaired heterologous immunity in aged ferrets during sequential influenza a h1n1 infection Virology 464-465 2014 177 183
176. K.N. Bossart, G. Zhu, and D. Middleton A neutralizing human monoclonal antibody protects against lethal disease in a ferret model of acute nipah virus infection PLoS Pathog. 5 2009 e1000642
177. Y.K. Chu, G.D. Ali, F. Jia, Q. Li, D. Kelvin, R.C. Couch, K.S. Harrod, J.A. Hutt, C. Cameron, S.R. Weiss, and C.B. Jonsson The SARS-CoV ferret model in an infection challenge study Virology 374 2008 151 163
178. H. Weingartl, M. Czub, S. Czub, J. Neufeld, P. Marszal, J. Gren, G. Smith, S. Jones, R. Proulx, Y. Deschambault, E. Grudeski, A. Andonov, R. He, Y. Li, J. Copps, A. Grolla, D. Dick, J. Berry, S. Ganske, L. Manning, and J. Cao Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets J. Virol. 78 2004 12672 12676
179. A.M. Zaki, S. van Boheemen, T.M. Bestebroer, A.D. Osterhaus, and R.A. Fouchier Isolation of a novel coronoavirus from a man with pneumonia in Saudi Arabia N. Engl. J. Med. 367 2012 1814 1820
180. C. Czerkinsky, and J. Holmgren Topical immunization strategies Mucosal Immunol. 3 2010 545 555
181. M. Bailey, Z. Christoforidou, and M.C. Lewis The evolutionary basis for differences between the immune systems of man, mouse, pig and ruminants Vet. Immunol. Immunopathol. 152 2013 13 19
182. R. Wernersson, M.H. Schierup, F.G. Jorgensen, J. Gorodkin, F. Panitz, H.H. Staerfeldt, O.F. Christensen, T. Mailund, H. Hornshoj, A. Klein, J. Wang, B. Liu, S.N. Hu, W. Dong, W. Li, G.K.S. Wong, J. Yu, C. Bendixen, M. Fredholm, S. Brunak, H.M. Yang, and L. Bolund Pigs in sequence space: A 0.66 × coverage pig genome survey based on shotgun sequencing BMC Genomics 6 2005
183. M.A. Groenen, A.L. Archibald, H. Uenishi, C.K. Tuggle, Y. Takeuchi, M.F. Rothschild, C. Rogel-Gaillard, C. Park, D. Milan, H.J. Megens, S. Li, D.M. Larkin, H. Kim, L.A. Frantz, M. Caccamo, H. Ahn, B.L. Aken, A. Anselmo, C. Anthon, L. Auvil, B. Badaoui, C.W. Beattie, C. Bendixen, D. Berman, F. Blecha, J. Blomberg, L. Bolund, M. Bosse, S. Botti, Z. Bujie, M. Bystrom, B. Capitanu, D. Carvalho-Silva, P. Chardon, C. Chen, R. Cheng, S.H. Choi, W. Chow, R.C. Clark, C. Clee, R.P. Crooijmans, H.D. Dawson, P. Dehais, F. De Sapio, B. Dibbits, N. Drou, Z.Q. Du, K. Eversole, J. Fadista, S. Fairley, T. Faraut, G.J. Faulkner, K.E. Fowler, M. Fredholm, E. Fritz, J.G. Gilbert, E. Giuffra, J. Gorodkin, D.K. Griffin, J.L. Harrow, A. Hayward, K. Howe, Z.L. Hu, S.J. Humphray, T. Hunt, H. Hornshoj, J.T. Jeon, P. Jern, M. Jones, J. Jurka, H. Kanamori, R. Kapetanovic, J. Kim, J.H. Kim, K.W. Kim, T.H. Kim, G. Larson, K. Lee, K.T. Lee, R. Leggett, H.A. Lewin, Y. Li, W. Liu, J.E. Loveland, Y. Lu, J.K. Lunney, J. Ma, O. Madsen, K. Mann, L. Matthews, S. McLaren, T. Morozumi, M.P. Murtaugh, J. Narayan, D.T. Nguyen, P. Ni, S.J. Oh, S. Onteru, F. Panitz, E.W. Park, H.S. Park, G. Pascal, Y. Paudel, M. Perez-Enciso, R. Ramirez-Gonzalez, J.M. Reecy, S. Rodriguez-Zas, G.A. Rohrer, L. Rund, Y. Sang, K. Schachtschneider, J.G. Schraiber, J. Schwartz, L. Scobie, C. Scott, S. Searle, B. Servin, B.R. Southey, G. Sperber, P. Stadler, J.V. Sweedler, H. Tafer, B. Thomsen, R. Wali, J. Wang, J. Wang, S. White, X. Xu, M. Yerle, G. Zhang, J. Zhang, J. Zhang, S. Zhao, J. Rogers, C. Churcher, and L.B. Schook Analyses of pig genomes provide insight into porcine demography and evolution Nature 491 2012 393 398
184. M. Mendicino, J. Ramsoondar, C. Phelps, T. Vaught, S. Ball, T. LeRoith, J. Monahan, S. Chen, A. Dandro, J. Boone, P. Jobst, A. Vance, N. Wertz, Z. Bergman, X.Z. Sun, I. Polejaeva, J. Butler, Y. Dai, D. Ayares, and K. Wells Generation of antibody- and b cell-deficient pigs by targeted disruption of the j-region gene segment of the heavy chain locus Transgenic Res. 20 2011 625 641
185. C.J. Phelps, S.F. Ball, T.D. Vaught, A.M. Vance, M. Mendicino, J.A. Monahan, A.H. Walters, K.D. Wells, A.S. Dandro, J.J. Ramsoondar, D.K. Cooper, and D.L. Ayares Production and characterization of transgenic pigs expressing porcine ctla4-ig Xenotransplantation 16 2009 477 485
186. Y. Luo, L. Lin, L. Bolund, T.G. Jensen, and C.B. Sorensen Genetically modified pigs for biomedical research J. Inherit. Metab. Dis. 35 2012 695 713
187. S. Suzuki, M. Iwamoto, Y. Saito, D. Fuchimoto, S. Sembon, M. Suzuki, S. Mikawa, M. Hashimoto, Y. Aoki, Y. Najima, S. Takagi, N. Suzuki, E. Suzuki, M. Kubo, J. Mimuro, Y. Kashiwakura, S. Madoiwa, Y. Sakata, A.C. Perry, F. Ishikawa, and A. Onishi Il2rg gene-targeted severe combined immunodeficiency pigs Cell Stem Cell 10 2012 753 758
188. G. Yang, B.L. Artiaga, T.J. Hackmann, M.S. Samuel, E.M. Walters, S. Salek-Ardakani, and J.P. Driver Targeted disruption of cd1d prevents nkt cell development in pigs Mamm. Genome 26 2015 264 270
189. V. Satyananda, H. Hara, M.B. Ezzelarab, C. Phelps, D. Ayares, and D.K. Cooper New concepts of immune modulation in xenotransplantation Transplantation 96 2013 937 945
190. K. Kuzmuck, and L. Schook Pigs as a model for biomedical sciences M. Rothschild, A. Ruvinsky, The Genetics of the Pig 2nd ed. 2011 AB International Oxfordshire, UK 426 444
191. J.K. Lunney Advances in swine biomedical model genomics Int. J. Biol. Sci. 3 2007 179 184
192. K. Kuzmuck, and L. Schook Pigs as a model for biomedical sciences M. Rothschild, A. Ruvinsky, The Genetics of the Pig 2nd ed. 2011 CAB International Oxfordshire, UK 426 444
193. S.J. Humphray, C.E. Scott, R. Clark, B. Marron, C. Bender, N. Camm, J. Davis, A. Jenks, A. Noon, M. Patel, H. Sehra, F. Yang, M.B. Rogatcheva, D. Milan, P. Chardon, G. Rohrer, D. Nonneman, P. de Jong, S.N. Meyers, A. Archibald, J.E. Beever, L.B. Schook, and J. Rogers A high utility integrated map of the pig genome Genome Biol. 8 2007 R139
194. K.H. Mair, C. Sedlak, T. Kaser, A. Pasternak, B. Levast, W. Gerner, A. Saalmuller, A. Summerfield, V. Gerdts, H.L. Wilson, and F. Meurens The porcine innate immune system: an update Dev. Comp. Immunol. 45 2014 321 343
195. H.K. Choi, W.E. Finkbeiner, and J.H. Widdicombe A comparative study of mammalian tracheal mucous glands J. Anat. 197 Pt 3 2000 361 372
196. S. Cunningham, Q.H. Meng, N. Klein, R.J. McAnulty, and S.L. Hart Evaluation of a porcine model for pulmonary gene transfer using a novel synthetic vector J. Gene Med. 4 2002 438 446
197. F.G. Hayden, R. Fritz, M.C. Lobo, W. Alvord, W. Strober, and S.E. Straus Local and systemic cytokine responses during experimental human influenza a virus infection. Relation to symptom formation and host defense J. Clin. Invest. 101 1998 643 649
198. S.T. Ballard, L. Trout, J. Garrison, and S.K. Inglis Ionic mechanism of forskolin-induced liquid secretion by porcine bronchi Am. J. Physiol. Lung Cell. Mol. Physiol. 290 2006 L97 104
199. S.T. Ballard, and S.K. Inglis Liquid secretion properties of airway submucosal glands J. Physiol. 556 2004 1 10
200. S.K. Inglis, M.R. Corboz, A.E. Taylor, and S.T. Ballard Regulation of ion transport across porcine distal bronchi Am. J. Physiol. 270 1996 L289 L297
201. A. Baskerville Development of the early lesions in experimental enzootic pneumonia of pigs: an ultrastructural and histological study Res. Vet. Sci. 13 1972 570 578
202. C.S. Rogers, D.A. Stoltz, D.K. Meyerholz, L.S. Ostedgaard, T. Rokhlina, P.J. Taft, M.P. Rogan, A.A. Pezzulo, P.H. Karp, O.A. Itani, A.C. Kabel, C.L. Wohlford-Lenane, G.J. Davis, R.A. Hanfland, T.L. Smith, M. Samuel, D. Wax, C.N. Murphy, A. Rieke, K. Whitworth, A. Uc, T.D. Starner, K.A. Brogden, J. Shilyansky, P.B. McCray Jr., J. Zabner, R.S. Prather, and M.J. Welsh Disruption of the cftr gene produces a model of cystic fibrosis in newborn pigs Science 321 2008 1837 1841
203. S.A. Dee, H.S. Joo, B.K. Park, T.W. Molitor, and G. Bruna Attempted elimination of porcine reproductive and respiratory syndrome virus from a seedstock farm by vaccination of the breeding herd and nursery depopulation Vet. Rec. 142 1998 569 572
204. X. Qi, and C. Lu Swine influenza virus: evolution mechanism and epidemic characterization-a review Wei Sheng Wu Xue Bao 49 2009 1138 1145
205. H.M. Yassine, C.W. Lee, R. Gourapura, and Y.M. Saif Interspecies and intraspecies transmission of influenza a viruses: viral, host and environmental factors Anim. Health Res. Rev. 11 2010 53 72
206. K. Van Reeth, S. Van Gucht, and M. Pensaert Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs Viral Immunol. 15 2002 583 594
207. M. Khatri, V. Dwivedi, S. Krakowka, C. Manickam, A. Ali, L. Wang, Z. Qin, G.J. Renukaradhya, and C.W. Lee Swine influenza h1n1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human h1n1 influenza virus J. Virol. 84 2010 11210 11218
208. H.J. Hirschberg, E. van Riet, D. Oosterhoff, J.A. Bouwstra, and G.F. Kersten Animal models for cutaneous vaccine delivery Eur. J. Pharm. Sci. 71 2015 112 122
209. D.S. Rajao, and A.L. Vincent Swine as a model for influenza a virus infection and immunity ILAR J. 56 2015 44 52
210. W.R. Hein, and P.J. Griebel A road less travelled: large animal models in immunological research Nat. Rev. Immunol. 3 2003 79 84
211. V. Dwivedi, C. Manickam, B. Binjawadagi, D. Joyappa, and G.J. Renukaradhya Biodegradable nanoparticle-entrapped vaccine induces cross-protective immune response against a virulent heterologous respiratory viral infection in pigs PLoS One 7 2012 e51794
212. A. Miyake, T. Akagi, Y. Enose, M. Ueno, M. Kawamura, R. Horiuchi, K. Hiraishi, M. Adachi, T. Serizawa, O. Narayan, M. Akashi, M. Baba, and M. Hayami Induction of hiv-specific antibody response and protection against vaginal shiv transmission by intranasal immunization with inactivated shiv-capturing nanospheres in macaques J. Med. Virol. 73 2004 368 377
213. G.J. Renukaradhya, X.J. Meng, J.G. Calvert, M. Roof, and K.M. Lager Inactivated and subunit vaccines against porcine reproductive and respiratory syndrome: current status and future direction Vaccine 2015
214. V. Dwivedi, C. Manickam, B. Binjawadagi, and G.J. Renukaradhya Plga nanoparticle entrapped killed porcine reproductive and respiratory syndrome virus vaccine helps in viral clearance in pigs Vet. Microbiol. 166 2013 47 58
215. V. Dwivedi, C. Manickam, R. Patterson, K. Dodson, M. Murtaugh, J.B. Torrelles, L.S. Schlesinger, and G.J. Renukaradhya Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant Vaccine 29 2011 4058 4066
216. J. Ren, H. Lu, S. Wen, W. Sun, F. Yan, X. Chen, J. Jing, H. Liu, C. Liu, F. Xue, P. Xiao, S. Xin, and N. Jin Enhanced immune responses in pigs by DNA vaccine coexpressing gp3 and gp5 of European type porcine reproductive and respiratory syndrome virus J. Virol. Methods 206 2014 27 37
217. I. Diaz, L. Darwich, G. Pappaterra, J. Pujols, and E. Mateu Immune responses of pigs after experimental infection with a European strain of porcine reproductive and respiratory syndrome virus J. Gen. Virol. 86 2005 1943 1951
218. N. Takikawa, S. Kobayashi, S. Ide, Y. Yamane, Y. Tanaka, and H. Yamagishi Detection of antibodies against porcine reproductive and respiratory syndrome (prrs) virus in swine sera by enzyme-linked immunosorbent assay J. Vet. Med. Sci. 58 1996 355 357
219. B. Spellberg, and J.E. Edwards Jr. Type 1/type 2 immunity in infectious diseases Clin. Infect. Dis. 32 2001 76 102
220. G. Taylor Bovine model of respiratory syncytial virus infection Curr. Top. Microbiol. Immunol. 372 2013 327 345
221. M.R. Ackermann Lamb model of respiratory syncytial virus-associated lung disease: insights to pathogenesis and novel treatments ILAR J. 55 2014 4 15
222. E.J. Kroeze, T. Kuiken, and A.D. Osterhaus Animal models Methods Mol. Biol. 865 2012 127 146